Stay updated on Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A recruitment-status indicator was added, signaling that the study is no longer recruiting participants. Additionally, new navigation/help items were added, the Interventions header formatting was standardized to Intervention/Treatment, and the revision tag was updated from v3.5.5 to v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-12T13:30:09.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision: v3.5.5 was added, replacing Revision: v3.5.4 on the page metadata.
    Difference
    0.0%
    Check dated 2026-06-05T08:47:00.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page's revision tag was updated to v3.5.4 and the previous v3.5.3 tag was removed, signaling a small update to the page’s revision history.
    Difference
    0.0%
    Check dated 2026-05-14T23:19:03.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Taoyuan District, Taiwan, 333 was removed and Taoyuan, Taiwan, 333 was added to the study locations in Taiwan. This updates the geographic coverage and enrollment options for participants in that region.
    Difference
    0.0%
    Check dated 2026-05-07T21:50:34.000Z thumbnail image
  7. Check
    46 days ago
    Change Detected
    Summary
    The page now displays revision v3.5.3, replacing the previous v3.5.2. This reflects a version update rather than a change to trial content.
    Difference
    0.0%
    Check dated 2026-04-30T15:37:52.000Z thumbnail image
  8. Check
    53 days ago
    Change Detected
    Summary
    City location text for Bucharest, Romania changed from the Romanian spelling (“București”) to the English spelling (“Bucharest”) while keeping the same address entry.
    Difference
    0.0%
    Check dated 2026-04-23T13:59:05.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Resectable NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Resectable NSCLC Clinical Trial page.